These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 6471586)
1. [Antinephritic effect of MD-805 [(2R, 4R) -4-methyl-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl) -L-arginyl] -2-piperidine-carboxylic acid monohydrate], a new antithrombin agent, on crescentic-type anti-GMB nephritis in rats]. Suzuki Y; Yamada H; Ito M Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):463-73. PubMed ID: 6471586 [No Abstract] [Full Text] [Related]
2. [Antinephritic effect of trimetazidine on nephrotic-type and crescentic-type anti-GBM nephritis in rats]. Suzuki Y; Ito M; Saito N Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):209-19. PubMed ID: 4021185 [No Abstract] [Full Text] [Related]
3. [Antinephritic effect of tiaramide on experimental nephritis in rats. (1). Effects on nephrotic-type and crescentic-type anti-GBM nephritis]. Suzuki Y; Ito M; Saito N; Nagamatsu T Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):251-61. PubMed ID: 6748338 [No Abstract] [Full Text] [Related]
4. Antinephritic effect of Y-19018, a thromboxane A synthetase inhibitor, on crescentic-type anti-GBM nephritis in rats. Suzuki Y; Tsukushi Y; Ito M; Nagamatsu T Jpn J Pharmacol; 1987 Oct; 45(2):177-85. PubMed ID: 3437587 [TBL] [Abstract][Full Text] [Related]
5. Heparin therapy in anti-basement membrane nephritis. Bone JM; Valdes AJ; Germuth FG; Lubowitz H Kidney Int; 1975 Aug; 8(2):72-9. PubMed ID: 1160229 [TBL] [Abstract][Full Text] [Related]
6. Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine. (2) Effect on crescentic-type anti-GBM nephritis in rats. Okamoto K; Ito M; Suzuki Y Jpn J Pharmacol; 1984 Jan; 34(1):33-41. PubMed ID: 6716716 [TBL] [Abstract][Full Text] [Related]
7. Studies on the antinephritic effects of plant components (6): antinephritic effects and mechanisms of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats (2). Hattori T; Furuta K; Hayashi K; Nagamatsu T; Ito M; Suzuki Y Jpn J Pharmacol; 1992 Nov; 60(3):187-95. PubMed ID: 1491511 [TBL] [Abstract][Full Text] [Related]
9. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin]. Monastyrskiĭ VA; Ambarova LI Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726 [TBL] [Abstract][Full Text] [Related]
10. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin. Bode W; Turk D; Stürzebecher J Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434 [TBL] [Abstract][Full Text] [Related]
11. [Fibrin deposits in Masugi nephritis and effects of urokinase, non-steroidal anti-inflammatory agents, anti-inflammatory enzymes and prostaglandins]. Sugizaki T Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):836-8. PubMed ID: 6663853 [No Abstract] [Full Text] [Related]
12. Studies on antinephritic effects of plant components (3): Effect of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms. Hattori T; Hayashi K; Nagao T; Furuta K; Ito M; Suzuki Y Jpn J Pharmacol; 1992 May; 59(1):89-96. PubMed ID: 1507662 [TBL] [Abstract][Full Text] [Related]
13. Nephrotoxic serum-induced nephritis in Wistar-Kyoto rats: a model to evaluate antinephritic agents. Kanno K; Okumura F; Toriumi W; Ishiyama N; Nishiyama S; Naito K Jpn J Pharmacol; 1998 Jun; 77(2):129-35. PubMed ID: 9681569 [TBL] [Abstract][Full Text] [Related]
14. Effect of dietary alpha-linolenate/linoleate balance on crescent type-anti-glomerular basement membrane nephritis in rats. Watanabe S; Suzuki E; Kojima R; Suzuki Y; Okuyama H Lipids; 1990 May; 25(5):267-72. PubMed ID: 1972260 [TBL] [Abstract][Full Text] [Related]
15. In vitro studies of a new synthetic thrombin inhibitor. Green D; Ts'ao C; Reynolds N; Kahn D; Kohl H; Cohen I Thromb Res; 1985 Jan; 37(1):145-53. PubMed ID: 3983896 [TBL] [Abstract][Full Text] [Related]
16. [Antinephritic effect of SA-446, an angiotensin I converting enzyme inhibitor, on crescentic-type anti-GBM nephritis in rats]. Suzuki Y; Ito M; Yamada H; Saitho N; Tsukushi Y Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1485-93. PubMed ID: 3007819 [No Abstract] [Full Text] [Related]
17. The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels. Yamashita T; Yamamoto J; Sasaki Y; Matsuoka A Thromb Res; 1993 Jan; 69(1):93-100. PubMed ID: 8465278 [TBL] [Abstract][Full Text] [Related]
18. Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals. Kumada T; Abiko Y Thromb Res; 1981 Nov; 24(4):285-98. PubMed ID: 6977887 [No Abstract] [Full Text] [Related]
20. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]